Different regulation of p27 and Akt during cardiomyocyte proliferation and hypertrophy

References

• Ahmed NN, Grimes HL, Bellacosa A, Chan TO, Tsichlis PN. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc Natl Acad Sci USA 1997; 94: 3627–3632
   PubMedGoogle Scholar
• Antos CL, McKinsey TA, Frey N, Kutschke W, McAnally J, Shelton JM, Richardson JA, Hill JA, Olson EN. Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 2002; 99: 907–912
   PubMed Web of Science ®Google Scholar
• Bartkova J, Lukas C, Sorensen CS, Meyts ER, Skakkebaek NE, Lukas J, Bartek J. Deregulation of the RB pathway in human testicular germ cell tumours. J Pathol 2003; 200: 149–156
   PubMedGoogle Scholar
• Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114: 763–776
   PubMed Web of Science ®Google Scholar
• Bricknell K, Brooks G. Over-expression of cyclin B1, but not cdc2, in neonathal cardiac myocytes extend their proliferative potential. Circulation 2002; 106, II-235
   Google Scholar
• Brooks G, Poolman RA, McGill CJ, Li JM. Expression and activities of cyclins and cyclin-dependent kinases in developing rat ventricular myocytes. J Mol Cell Cardiol 1997; 29: 2261–2271
   PubMed Web of Science ®Google Scholar
• Brooks G, Poolman RA, Li JM. Arresting developments in the cardiac myocyte cell cycle: Role of cyclin-dependent kinase inhibitors. Cardiovasc Res 1998; 39: 301–311
   PubMed Web of Science ®Google Scholar
• Busk PK, Hinrichsen R. Cyclin D in left ventricle hypertrophy. Cell Cycle 2003; 2: 91–95
   PubMedGoogle Scholar
• Busk PK, Bartkova J, Strom CC, Wulf-Andersen L, Hinrichsen R, Christoffersen TE, Latella L, Bartek J, Haunso S, Sheikh SP. Involvement of cyclin D activity in left ventricle hypertrophy in vivo and in vitro. Cardiovasc Res 2002; 56: 64–75
   PubMedGoogle Scholar
• Busk PK, Hinrichsen R, Bartkova J, Hansen AH, Christoffersen TE, Bartek J, Haunso S. Cyclin D2 induces proliferation of cardiac myocytes and represses hypertrophy. Exp Cell Res 2005; 304: 149–161
   PubMed Web of Science ®Google Scholar
• Chen C, Sytkowski AJ. Erythropoietin activates two distinct signaling pathways required for the initiation and the elongation of c-myc. J Biol Chem 2001; 276: 38518–38526
   PubMedGoogle Scholar
• Chien K, Grace A, Hunter JJ. Molecular and cellular biology of cardiac hypertrophy and failure. Saunders, Philidelphia, PA 1999; 211–250
   Google Scholar
• Crackower MA, Oudit GY, Kozieradzki I, Sarao R, Sun H, Sasaki T, Hirsch E, Suzuki A, Shioi T, Irie-Sasaki J, Sah R, Cheng HY, Rybin VO, Lembo G, Fratta L, Oliveira-dos-Santos AJ, Benovic JL, Kahn CR, Izumo S, Steinberg SF, Wymann MP, Backx PH, Penninger JM. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signalling pathways. Cell 2002; 110: 737–749
   PubMed Web of Science ®Google Scholar
• Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995; 378: 785–789
   PubMed Web of Science ®Google Scholar
• Diehl JA, Zindy F, Sherr CJ. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev 1997; 11: 957–972
   PubMed Web of Science ®Google Scholar
• Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev 1998; 12: 2245–2262
   PubMed Web of Science ®Google Scholar
• Flink IL, Oana S, Maitra N, Bahl JJ, Morkin E. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes. J Mol Cell Cardiol 1998; 30: 563–578
   PubMedGoogle Scholar
• Gille H, Downward J. Multiple ras effector pathways contribute to G(1) cell cycle progression. J Biol Chem 1999; 274: 22033–22040
   PubMed Web of Science ®Google Scholar
• Goldstein MA, Claycomb WC, Schwartz A. DNA synthesis and mitosis in well-differentiated mammalian cardiocytes. Science 1974; 183: 212–213
   PubMedGoogle Scholar
• Haq S, Choukroun G, Kang ZB, Ranu H, Matsui T, Rosenzweig A, Molkentin JD, Alessandrini A, Woodgett J, Hajjar R, Michael A, Force T. Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy. J Cell Biol 2000; 151: 117–130
   PubMedGoogle Scholar
• Higgins P, Rozengurt E. Stimulation of DNA synthesis in quiescent 3T3 cells. Academic Press, San Diego 1994; 294–301
   Google Scholar
• Horky M, Kuchtickova S, Vojtesek B, Kolar F. Induction of cell-cycle inhibitor p21 in rat ventricular myocytes during early postnatal transition from hyperplasia to hypertrophy. Physiol Res 1997; 46: 233–235
   PubMedGoogle Scholar
• Jones SM, Kazlauskas A. Growth factor-dependent signaling and cell cycle progression. Chem Rev 2001; 101: 2413–2423
   PubMed Web of Science ®Google Scholar
• Koh KN, Kang MJ, Frith-Terhune A, Park SK, Kim I, Lee CO, Koh GY. Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development. J Mol Cell Cardiol 1998; 30: 463–474
   PubMed Web of Science ®Google Scholar
• Liang J, Slingerland JM. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2003; 2: 339–345
   PubMed Web of Science ®Google Scholar
• Li JM, Poolman RA, Brooks G. Role of G1 phase cyclins and cyclin-dependent kinases during cardiomyocyte hypertrophic growth in rats. Am J Physiol 1998; 275: H814–H822
   PubMed Web of Science ®Google Scholar
• Markou T, Yong CS, Sugden PH, Clerk A. Regulation of protein kinase C delta by phorbol ester, endothelin-1, and platelet-derived growth factor in cardiac myocytes. J Biol Chem 2006; 281: 8321–8331
   PubMedGoogle Scholar
• Matsui T, Tao J, del Monte F, Lee KH, Li L, Picard M, Force TL, Franke TF, Hajjar RJ, Rosenzweig A. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 2001; 104: 330–335
   PubMed Web of Science ®Google Scholar
• Matsui T, Li L, Wu JC, Cook SA, Nagoshi T, Picard MH, Liao R, Rosenzweig A. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem 2002; 277: 22896–22901
   PubMed Web of Science ®Google Scholar
• McDevitt TC, Laflamme MA, Murry CE. Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway. J Mol Cell Cardiol 2005; 39: 865–873
   PubMed Web of Science ®Google Scholar
• Nevins JR. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ 1998; 9: 585–593
   PubMedGoogle Scholar
• Piper HM, Volz A, Schwartz P. Cell culture techniques in heart and vessel research. Springer Verlag, Berlin 1990; 36–60
   Google Scholar
• Poolman RA, Gilchrist R, Brooks G. Cell cycle profiles and expressions of p21CIP1 and P27KIP1 during myocyte development. Int J Cardiol 1998; 67: 133–142
   PubMed Web of Science ®Google Scholar
• Price RL, Haley ST, Bullard TA, Goldsmith EC, Simpson DG, Thielen TE, Yost MJ, Terracio L. Effects of platelet-derived growth factor-AA and -BB on embryonic cardiac development. Anat Rec A Discov Mol Cell Evol Biol 2003; 272: 424–433
   Google Scholar
• Reiss K, Cheng W, Ferber A, Kajstura J, Li P, Li B, Olivetti G, Homcy CJ, Baserga R, Anversa P. Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc Natl Acad Sci USA 1996; 93: 8630–8635
   PubMed Web of Science ®Google Scholar
• Rimerman RA, Gellert-Randleman A, Diehl JA. Wnt1 and MEK1 cooperate to promote cyclin D1 accumulation and cellular transformation. J Biol Chem 2000; 275: 14736–14742
   PubMed Web of Science ®Google Scholar
• Sears RC, Nevins JR. Signaling networks that link cell proliferation and cell fate. J Biol Chem 2002; 277: 11617–11620
   PubMedGoogle Scholar
• Servant MJ, Coulombe P, Turgeon B, Meloche S. Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms. J Cell Biol 2000; 148: 543–556
   PubMed Web of Science ®Google Scholar
• Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev 1997; 11: 1464–1478
   PubMed Web of Science ®Google Scholar
• Sherr CJ, Roberts JM. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 1999; 13: 1501–1512
   PubMed Web of Science ®Google Scholar
• Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, Lawitts J, Cantley LC, Izumo S. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. Embo J 2000; 19: 2537–2548
   PubMed Web of Science ®Google Scholar
• Shioi T, McMullen JR, Kang PM, Douglas PS, Obata T, Franke TF, Cantley LC, Izumo S. Akt/protein kinase B promotes organ growth in transgenic mice. Mol Cell Biol 2002; 22: 2799–2809
   PubMed Web of Science ®Google Scholar
• Simpson P. Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response. J Clin Invest 1983; 72: 732–738
   PubMed Web of Science ®Google Scholar
• Sugden PH, Clerk A. Cellular mechanisms of cardiac hypertrophy. J Mol Med 1998; 76: 725–746
   PubMed Web of Science ®Google Scholar
• Sutterluty H, Chatelain E, Marti A, Wirbelauer C, Senften M, Muller U, Krek W. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol 1999; 1: 207–214
   PubMed Web of Science ®Google Scholar
• Tamamori-Adachi M, Ito H, Sumrejkanchanakij P, Adachi S, Hiroe M, Shimizu M, Kawauchi J, Sunamori M, Marumo F, Kitajima S, Ikeda MA. Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation. Circ Res 2003; 92: e12–e19
   PubMed Web of Science ®Google Scholar
• Tyers M, Jorgensen P. Proteolysis and the cell cycle: With this RING I do thee destroy. Curr Opin Genet Dev 2000; 10: 54–64
   PubMed Web of Science ®Google Scholar
• Urbanek K, Quaini F, Tasca G, Torella D, Castaldo C, Nadal-Ginard B, Leri A, Kajstura J, Quaini E, Anversa P. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci USA 2003; 100: 10440–10445
   PubMed Web of Science ®Google Scholar
• Vara D, Bicknell KA, Coxon CH, Brooks G. Inhibition of E2F abrogates the development of cardiac myocyte hypertrophy. J Biol Chem 2003; 278: 21388–21394
   PubMed Web of Science ®Google Scholar
• von Harsdorf R, Hauck L, Mehrhof F, Wegenka U, Cardoso MC, Dietz R. E2F-1 overexpression in cardiomyocytes induces downregulation of p21CIP1 and p27KIP1 and release of active cyclin-dependent kinases in the presence of insulin-like growth factor I. Circ Res 1999; 85: 128–136
   PubMed Web of Science ®Google Scholar
• Wolf G. Molecular mechanisms of renal hypertrophy: Role of p27Kip1. Kidney Int 1999; 56: 1262–1265
   PubMedGoogle Scholar
• Wolf G, Reinking R, Zahner G, Stahl RA, Shankland SJ. Erk 1,2 phosphorylates p27(Kip1): Functional evidence for a role in high glucose-induced hypertrophy of mesangial cells. Diabetologia 2003; 46: 1090–1099
   PubMedGoogle Scholar
• Yoshizumi M, Lee WS, Hsieh CM, Tsai JC, Li J, Perrella MA, Patterson C, Endege WO, Schlegel R, Lee ME. Disappearance of cyclin a correlates with permanent withdrawal of cardiomyocytes from the cell cycle in human and rat hearts. J Clin Invest 1995; 95: 2275–2280
   PubMedGoogle Scholar